Phase 1 MCRC Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma

Colorectal Cancer (CRC)Metastatic Colorectal Carcinoma (mCRC)Adenomatous Polyposis Coli (APC) Gene Mutation+1 more

HonorHealth Research Institute126 enrolled1 locationNCT07463599

Recruiting

Phase 1Phase 2

A Clinical Study of Arfolitixorin in Patients With mCRC

Metastatic Colorectal Cancer (Mcrc)

Isofol Medical AB60 enrolled1 locationNCT06922383